Gilbert Cisneros conducts multiple transactions in stocks including Agios Pharmaceuticals and Airbnb

Published 12/02/2025, 22:46
Gilbert Cisneros conducts multiple transactions in stocks including Agios Pharmaceuticals and Airbnb

In recent investment activities, Gilbert Cisneros, the representative for California’s 31st congressional district, has made a series of stock transactions. These transactions were conducted through various investment vehicles, including Bank of America, Pershing Advisor Solutions LLC Brokerage, and Wells Fargo (NYSE:WFC) Advisors, all under the umbrella of the 150 Main Street Trust.

Among the transactions, Cisneros made purchases of common stocks in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), APi Group Corporation (NYSE:APG), and Microsoft Corporation (NASDAQ:MSFT), each valued between $1,001 and $15,000. According to InvestingPro data, AGIO, with a market cap of $1.87 billion, currently maintains a GOOD financial health score and shows strong liquidity with a current ratio of 8.99. Analysts maintain a bullish outlook on the stock, which appears undervalued based on InvestingPro’s Fair Value analysis.

In addition, he made a notable purchase in CACI International, Inc. Class A Common Stock (NYSE:CACI) valued between $15,001 and $50,000. Another significant transaction was the purchase of Hawaiian Electric Industries, Inc. Common Stock (NYSE:HE), valued between $50,001 and $100,000.

Cisneros also purchased options in Broadcom Inc. - Common Stock (NASDAQ:AVGO) and Constellation Brands, Inc. Common Stock (NYSE:STZ), each valued between $1,001 and $15,000. The Broadcom option has a strike price of $215 and expires in February 2025, while the Constellation Brands option has a strike price of $205 and expires in January 2025.

On the selling side, Cisneros sold shares in Airbnb, Inc. - Class A Common Stock (NASDAQ:ABNB), Boeing Company (NYSE:BA), and Broadcom Inc. - Common Stock (NASDAQ:AVGO), each valued between $1,001 and $15,000. He also partially sold shares in DENTSPLY SIRONA Inc. - Common Stock (NASDAQ:XRAY) and Johnson & Johnson Common Stock (NYSE:JNJ), each within the same value range.

In addition to these transactions, Cisneros sold U.S. Treasury Bills (CBOE:GS) valued between $250,001 and $500,000.

These transactions reflect the active investment approach of the representative, who continues to diversify his portfolio through various stocks and investment vehicles. For investors seeking deeper insights, InvestingPro reveals that AGIO has achieved 37% revenue growth in the last twelve months, with 8 additional ProTips available to subscribers through the platform’s comprehensive research reports covering 1,400+ US equities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.